... with the Sahlgrenska Academy at Gothenburg University in Sweden may lead to new treatments for blood cancer and other diseases. By stopping the production of a specific enzyme, ICMT, researchers were ...
A new study has shown that susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient's DNA, which is prone to developing ...
... heavily promoted for use in patients with primary myelofibrosis (PMF), a form of blood cancer often treated with blood transfusion. These drugs, however, which withhold available iron in the body, ...
... risk of developing an increasingly common type of blood cancer, according to a study published online today ... tumors develop in lymphocytes, a type of white blood cell. Follicular lymphoma arises from B ...
... bone marrow transplants and may improve care for blood cancer patients according to research from Rush University ... few months.
There are over 250,000 new cancer patients per year who require or would ...
... gene called TMPRSS2.
Before this discovery, it was thought that gene fusions only occurred in blood cancers, such as leukemias and lymphomas, but not in common solid tumors such as prostate cancer. ...
A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research.
Nearly a year after federal epidemiologists first sounded the alarm over a cluster of rare blood cancers in northeastern Pennsylvania, their research has zeroed in on a hardscrabble region 80 miles ...
... treatments for heart diseases, anemias, leukemia and other blood cancers, and autoimmune diseases because they show ... blood stem cells with the right culture conditions," says Elias Zambidis, M.D., Ph ...
... cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression ... family members were missing. And while unmodified blood stem cells give rise to two ...
... may one day help in the development of targeted therapies for leukemia, multiple myeloma and other cancers of the blood.
The researchers, led by Kristin T. Chun, Ph.D., assistant professor of ...
... the toxic effects of chemotherapy in children and adults. Their findings may one day help in the development of targeted therapies for leukemia, multiple myeloma and other cancers of the blood.
... , particularly when combined with chemotherapy.
Castro said that ISF35 also has the "potential to treat a range of blood cancers including lymphomas and even certain types of breast and lung cancers ...
... is difficult. A new study published in Pediatric Blood & Cancer evaluated a phase II clinical trial ... tumors due to the significant impact of the drug on blood counts," says Steven DuBois, co-author of ...
... greatly improves the animals' ability to eliminate cancer cells such as melanoma (a skin cancer) and lymphoma (a blood cancer). Mice lacking the CRACC gene, generated in Dr. Veillette's laboratory, ...
